tiprankstipranks
Luye Pharma Group Ltd. (LYPHF)
OTHER OTC:LYPHF
US Market
LYPHF
Luye Pharma Group
RESEARCH TOOLSreports

Luye Pharma Group (LYPHF) Stock News & Sentiment

3 Followers
Luye Pharma Starts Phase II Trial in China for Next-Generation Schizophrenia Drug LY03020
Premium
Company Announcements
Luye Pharma Starts Phase II Trial in China for Next-Generation Schizophrenia Drug LY03020
6d ago
Luye Pharma Delivers Double-Digit Profit Growth in 2025 but Skips Dividend
Premium
Company Announcements
Luye Pharma Delivers Double-Digit Profit Growth in 2025 but Skips Dividend
15d ago
Luye Pharma Sets March 2026 Board Meeting to Approve 2025 Results
Premium
Company Announcements
Luye Pharma Sets March 2026 Board Meeting to Approve 2025 Results
28d ago
Luye Pharma Completes RMB1.09 Billion Transfer of 25% Stake in Nanjing Luye to NJ Xinshi
Premium
Company Announcements
Luye Pharma Completes RMB1.09 Billion Transfer of 25% Stake in Nanjing Luye to NJ Xinshi
3M ago
Luye Pharma Injects RMB285 Million into Nanjing Unit via Structured Deal
Premium
Company Announcements
Luye Pharma Injects RMB285 Million into Nanjing Unit via Structured Deal
3M ago
Luye Pharma’s Ruoxinlin NDA for Anxiety Disorder Accepted in China, Targeting Major CNS Market Gap
Premium
Company Announcements
Luye Pharma’s Ruoxinlin NDA for Anxiety Disorder Accepted in China, Targeting Major CNS Market Gap
3M ago
Luye Pharma Adds Independent Director Xia Lian to Nomination Committee
Premium
Company Announcements
Luye Pharma Adds Independent Director Xia Lian to Nomination Committee
3M ago
More LYPHF News >

LYPHF News on the Web

Luye Pharma Starts Phase II Trial in China for Next-Generation Schizophrenia Drug LY03020
TipRanks News
Bullish
Luye Pharma Sets March 2026 Board Meeting to Approve 2025 Results
TipRanks News
Neutral
Luye Pharma Completes RMB1.09 Billion Transfer of 25% Stake in Nanjing Luye to NJ Xinshi
TipRanks News
Neutral
Luye Pharma Injects RMB285 Million into Nanjing Unit via Structured Deal
TipRanks News
Neutral
Luye Pharma’s Ruoxinlin NDA for Anxiety Disorder Accepted in China, Targeting Major CNS Market Gap
TipRanks News
Bullish
Luye Pharma’s Five New Drugs Gain Inclusion in China’s 2025 Reimbursement Lists
TipRanks News
Neutral
Luye Pharma Reports Revenue Growth Amid Profit Decline
TipRanks News
Neutral
Luye Pharma Announces Partial Conversion of Convertible Bonds
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
LYPHF
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LYPHF’s Media Buzz Sentiment?
1 articles about LYPHF were published this week. In an average week, 1 articles are published.
    What is LYPHF’s weekly average amount of articles?
    In an average week, 1 articles about LYPHF are published.
      What is LYPHF’s News Sentiment?
      100% of articles about LYPHF were positive this week, compared to its sector average of 60%.
        Healthcare Stocks that are Trending in the News
        SZYCFSaizeriya Co
        THXThor Explorations
        0J3FSodexo SA
        LUCALuca Mining
        0RJIAnheuser Busch InBev SA/NV
        Showing the stocks with the most bullish news sentiment over the past week